Skip to main content

Table 2 Mean (SD) CGI-S and CGI-I scores for prior AMPH subgroup and overall efficacy population

From: Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study

Variable Mean (SD) CGI scores
Prior AMPH subgroup Overall efficacy population
Placebo (n = 2) LDX (n = 39) Placebo (n = 62) LDX (n = 352)
CGI-S (Baseline) 4.5 (0.71) 4.9 (0.76) 4.7 (0.73) 4.8 (0.65)
CGI-I (Endpoint) 2.5 (0.71) 2.4 (1.11) 3.2 (1.19) 2.4 (1.07)